Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer-Reference-Cited by-同舟云学术

Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer

Published:2011-10-25 Issue:13 Volume:118 Page:3236-3243
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Livi Lorenzo,Meattini Icro,Saieva Calogero,Franzese Ciro,Di Cataldo Vanessa,Greto Daniela,Franceschini Davide,Scotti Vieri,Bonomo Pierluigi,Nori Jacopo,Sanchez Luis,Vezzosi Vania,Bianchi Simonetta,Cataliotti Luigi,Biti Giampaolo

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26647/fullpdf

Reference24 articles.

1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science.,1989

2. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer;Buzdar;J Clin Oncol.,2005

3. Trastuzumab plus adjuvant chemotherapy for operable: HER2-positive breast cancer;Romond;N Engl J Med.,2005

4. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med.,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2023-04

2. Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up;Breast Cancer Research and Treatment;2022-12-05

3. Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study;Breast Cancer Research and Treatment;2022-08-06

4. Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer;Medicine;2022-06-24

5. Adjuvant Therapy;Modern Breast Cancer Imaging;2021-11-01